Bucket, do you know the name of another biotech firm that focuses on cancer drugs, has an Alzheimer's drug, and has a promising antibiotic in preclincal status? Also, the stock has to be below $6. If so, I will likely buy some of the company's shares. Thanks in advance.
I see you didn't mention that they will start burning through cash and that their about to have the generic anvil dropped on them. By all means buy more shares. I have my lawnchair out and can sit back and wait this out. We will see if it stays about $5.40 by Friday. You are still down $1.08 from where you stated we were headed to $15. The antibiotic may trigger some more payouts, so sometimes you get what you wish for.
Competition will announce bigger and bolder plans, 3 years soonier than astex, just keep that in mind. I am snooping around, trying to see response rates on rigosertib.